News

Oncologists and scientists warn that extensive cuts to mRNA funding will have devastating impacts on cancer vaccine ...
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS ...
Moderna has secured approval from Health Canada for Spikevax, its updated Covid-19 mRNA vaccine, which targets the SARS-CoV-2 ...
Investing.com -- Moderna Inc (NASDAQ:MRNA) stock fell 5.5% and Pfizer Inc (NYSE:PFE) shares dropped 2.6% following reports from Newsweek and The Daily Beast that the Trump administration may be ...
The Trump administration said it was terminating mRNA vaccine research and shifting focus to other approaches, including a ...
The biotech company said Friday the latest version of its Covid-19 mRNA vaccine, Spikevax, has been authorized by Health Canada. And for the first time, all pre-filled syringe doses of the vaccine ...
Despite questions coming from federal changes, Colorado’s chief medical officer says he thinks “there will be enough vaccines ...
The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...
Moderna also said it provided the FDA with additional follow-up data on its vaccine for children ages 12 to 17. Children that age would get two shots of a larger 100-microgram version of the vaccine.
All pre-filled syringe doses for the Canadian market will be manufactured domestically for the first time, with drug ...
CAMBRIDGE, MA / ACCESS Newswire / August 21, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced its participation in the ...
An update to Moderna's COVID-19 vaccine that targets the newest variants and is made entirely within Canada's borders was just approved by Health Canada.